We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

woensdag 26 april 2017

Latest content from npj Schizophrenia: 26 April 2017

If you are unable to see the message below, click here to view.

Advertisement
Open for Submissions

An interdisciplinary journal dedicated to publishing high-quality open research relevant to all aspects of schizophrenia and psychosis.

Explore the benefits of submitting your next research article.

Table of Contents: April 2017

Article | 19 April 2017

Isoform specific differences in phospholipase C beta 1 expression in the prefrontal cortex in schizophrenia and suicide

M. Udawela, E. Scarr, S. Boer, J. Y. Um, A. J. Hannan et al.

npj Schizophr 3, Article number: s41537-017-0020-x |  doi: 10.1038/s41537-017-0020-x

Article | 13 April 2017

Thought disorder measured as random speech structure classifies negative symptoms and schizophrenia diagnosis 6 months in advance

Natália B. Mota, Mauro Copelli, Sidarta Ribeiro

npj Schizophr 3, Article number: s41537-017-0019-3 |  doi: 10.1038/s41537-017-0019-3

Article | 6 April 2017

Decreased free d-aspartate levels are linked to enhanced d-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patients

Tommaso Nuzzo, Silvia Sacchi, Francesco Errico, Simona Keller, Orazio Palumbo et al.

npj Schizophr 3, Article number: s41537-017-0015-7 |  doi: 10.1038/s41537-017-0015-7

Review Article | 10 April 2017

Dopamine D2 receptors and the circadian clock reciprocally mediate antipsychotic drug-induced metabolic disturbances

Zachary Freyberg, Michael J. McCarthy

npj Schizophr 3, Article number: s41537-017-0018-4 |  doi: 10.1038/s41537-017-0018-4

Review Article | 3 April 2017

Brain structure, function, and neurochemistry in schizophrenia and bipolar disorder—a systematic review of the magnetic resonance neuroimaging literature

Badari Birur, Nina Vanessa Kraguljac, Richard C. Shelton, Adrienne Carol Lahti

npj Schizophr 3, Article number: s41537-017-0013-9 |  doi: 10.1038/s41537-017-0013-9

Your email address is in the mailing list.
You have been sent this alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: myaccount (You will need to log in to be recognised as a nature.com registrant)
For further technical assistance, please contact our registration department
For print subscription enquiries, please contact our subscription department
For other enquiries, please contact our customer feedback department
Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
Springer Nature